Features | Partner Sites | Information | LinkXpress
Sign In
PZ HTL SA
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

High-Performance Calorimeter Enables Superior Materials Analysis and Development

By BiotechDaily International staff writers
Posted on 30 Apr 2013
Image: Shimadzu’s DSC-60 Plus series new differential scanning calorimeter (Photo courtesy of Shimadzu).
Image: Shimadzu’s DSC-60 Plus series new differential scanning calorimeter (Photo courtesy of Shimadzu).
A new, simple-to-operate, differential scanning calorimeter incorporates new technology designed to offer high sensitivity and resolution required for materials characterization in R&D and quality control applications for areas such as pharmaceuticals, polymers, etc.

Shimadzu (Kyoto, Japan) introduces their new thermal analyzer, the DSC-60 Plus series differential scanning calorimeter (DSC), for the analysis and development of high-performance, highly functional materials. In addition to top-class sensitivity and resolution, a new detector and a unique furnace construction achieve a noise level of less than 0.5 μW, providing a stable baseline from ultralow to high temperatures—across the entire measured temperature range (-140–600 °C). It also features a wide dynamic measurement range of ±150 mW (extended three times compared to previous Shimadzu instruments).

The DSC-60 Plus enables diverse and complex calorimetric measurements via simple operations. A cooling chamber with a liquid-nitrogen option permits easy measurements below room temperature (RT) - extremely convenient as it eliminates the need to install special accessories. A sample loading temperature function (SLTF) enables quick sample change during sequential analysis: while running a series of analyses below RT, the furnace temperature must be returned to near RT during sample replacement—the SLTF heats only the region around the sample when the sample is replaced, so that measurement can be rapidly resumed without moisture condensation.

The DSC-60 Plus is also eco-friendly. The newly designed furnace unit reduces energy consumption by over 20%, as measured when heating from RT to 300 °C at a 20 °C/minute heating rate (compared to previous Shimadzu instruments). When making measurements below RT, the liquid-nitrogen consumption savings exceed 30% (compared to previous Shimadzu instruments). The instrument footprint (W: 320 x H: 500 x D: 500 (mm)) has also been minimized.

The DSC-60 Plus series complies with various guidelines and regulations involving analytical laboratories, such as the PIC/S GMP guidelines, and electronic record/electronic signature (ER/ES) regulations and policies, including the US FDA 21 CFR Part11. In addition, it is compatible with various other analytical instruments and connected network systems, helping to ensure overall laboratory compliance.

Related Links:

Shimadzu



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: This novel, flexible film that can react to light is a promising step toward an artificial retina (Photo courtesy of the American Chemical Society).

Novel Nanofilm May Be Artificial Retina Precursor

Researchers have used advanced nanotechnology techniques to develop a light-sensitive film that has potential for future artificial retina applications. Investigators at the Hebrew University of Jerusalem... Read more

Drug Discovery

view channel
Image: Disruption and removal of malaria parasites by the experimental drug (+)-SJ733 (Photo courtesy of the University of California, San Francisco).

Experimental Antimalaria Drug Induces the Immune System to Destroy Infected Red Blood Cells

An experimental drug for the treatment of malaria was found to induce morphological changes in infected erythrocytes that enabled the immune system to recognize and eliminate them. Investigators at... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Business

view channel

R&D Partnership Initiated to Reduce Development Time for New Drugs

nanoPET Pharma, GmbH (Berlin, Germany) signed an open-ended framework contract with the international pharmaceutical company Boehringer Ingelheim (Ridgefield, CT, USA). By developing customized contrast agents for research in both basic and preclinical studies, nanoPET Pharma will contribute to the enhancement of Boehringer... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.